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We have developed an in vitro system for detailed analysis of reversible phosphorylation of the plant mitochondrial pyruvate
dehydrogenase complex, comprising recombinant Arabidopsis thaliana α2β2-heterotetrameric pyruvate dehydrogenase (E1) plus
A. thaliana E1-kinase (AtPDK). Upon addition of MgATP, Ser292, which is located within the active-site loop structure of E1α,i s
phosphorylated. In addition to Ser292, Asp295 and Gly297 are highly conserved in the E1α active-site loop sequences. Mutation
of Asp295 to Ala, Asn, or Leu greatly reduced phosphorylation of Ser292, while mutation of Gly297 had relatively little eﬀect.
Quantitative two-hybrid analysiswas used to show that mutation of Asp295 did not substantially aﬀe c tb i n d i n go fA t P D Kt oE 1 α.
When using pyruvate as a variable substrate, the Asp295 mutant proteins had modest changes in kcat, Km,a n dkcat/Km values.
Therefore, we propose that Asp295 plays an important role in stabilizing the active-site loop structure, facilitating transfer of the
γ-phosphate from ATP to the Ser residue at regulatory site one of E1α.
1.Introduction
The α-ketoacid dehydrogenase complexescomprise a unique
family of large multienzyme structures, including the
pyruvate-, α-ketoglutarate-, and branched-chain α-ketoacid
dehydrogenase complexesand the related glycine decarboxy-
lase complex [1–5]. These complexes have molecular mass
values from 4 to 9MDa and are among the largest non-viral
protein assemblies. All family members have multiple copies
of three central enzymes: E1, an α-ketoacid decarboxy-
lase/dehydrogenase; E2, a dihydrolipoyl acyltransferase; E3,
a dihydrolipoyl dehydrogenase. The overall reaction converts
the α-ketoacid, NAD+, and reduced coenzyme A to CO2,
NADH,and an acyl-CoA. The complexesare deﬁned bytheir
α-ketoacid speciﬁcity
In prokaryotic cells the α-ketoacid dehydrogenase com-
plexes are localized in the cytoplasm, while in eukaryotic
cells they are within the mitochondrial matrix. Plant cells
have a second form of the pyruvate dehydrogenase complex
(PDC) which is localized within the plastid stroma [1, 2]. In
addition to subcellular compartmentation, the activities of
all of the complexes are regulated by product inhibition. The
branched-chain α-ketoacid dehydrogenase complexes(BCK-
DCs) and mitochondrial PDCs are additionally regulated by
reversible phosphorylation, mediated by intrinsic E1-kinases
[1–3, 6] and P-E1-phosphatases [6, 7].
The PDC E1α active-site loop includes two (sites 1 and
2) of the three phosphorylation sites present in mammalian
PDC (Figure 1). Plant PDC E1α sequences include a con-
served Serresidue corresponding to mammalian phosphory-
lation site 1 and a Serresidue one position upstream ofsite 2.
The Asp295 residue, conserved in both PDC and BCKDC
E1α subunits, islocated three residues from phosphorylation
site 1. The results from studies using peptide substrates2 Enzyme Research
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Figure 1: Molecular modeling and in silico mutagenesis of the active-site loop of AtPDC E1α. (a) Alignment of residues in the active-
site loop of α-ketoacid dehydrogenase E1α sequences. Numbering is based upon the A. thaliana PDC E1α sequence. The plant mtPDC
sequence is identical in Pisum sativum, A. thaliana, Glycine max, Lycopersicon esculentum, Solanum tuberosum, Beta vulgaris, Nicotiana
tabacum, Populus hybrida, Lotus corniculatus, Medicago truncatula, Zea mays,andOryza sativum. The mammalianPDCsequence is identical
in Rattus norvegicus, Mus musculus,a n dHomo sapiens. The nematode PDC sequence is identical in Ascaris suum and Caenorhabditis
elegans.The yeastPDC sequence is identical inSaccharomyces cerevisiae, Schizosaccharomyces pombe,a n dKluyveromyces lactis. Bacterial PDC
sequences are identical from Bacillus subtilis and Bacillus stearothermophilus. The mammalian BCKDC sequence is identical in H. sapiens,
M. musculus,a n dOvis aries. The bacterial BCKDC sequence is from B. subtilis. The carats denote the Asp and Gly residues targeted in this
study. The red underlined Ser residues correspond to mammalian pyruvate dehydrogenase phosphorylation sites 1 and 2 and mammalian
BCKDC phosphorylation site 2. (b) The consensus active-site loop primary sequence presented as output from the WebLogo program [9].
(c) Carbon-alpha trace from modeling of residues His-291 to Arg-301 in the active site loop of AtE1α. The same colors have been used for
each residue in all panels. Hydrogen bonds are indicated with green dashed lines. Traces were built using Swiss-PDB viewer (version 3.7).
indicate that this residue is important for phosphorylation
of E1 at site 1, and it has been proposed to be involved
with PDK binding [8]. The Gly297 residue is conserved only
in forms of PDC E1 that are phosphorylated, and there is
a corresponding Ser residue in the BCKDC E1α sequences.
This suggests that a small residue in this position is required
for an appropriate conformation of the active-site loop for
E1 phosphorylation.
Limited proteolysis has been used to probe the reaction
mechanism of the dehydrogenase/decarboxylase (E1) com-
ponent of mammalian α-ketoacid dehydrogenase complexes
[10–13]. In all cases, loss of catalytic activity resulted
from cleavage of the E1α subunit, while E1β remained
unaﬀected.Limited proteolysisofBacillus stearothermophilus
PDC revealed that it is the surface loop of the E1α subunit
structure that is susceptible to cleavage [14]. In the crystal
structures of the BCKDC E1 from Pseudomonas putida [15]
and Homo sapiens [16] and of the PDC E1 from H. sapiens
[17], it is clear that this loop lies in the funnel-shaped
active site formed by the E1α and E1β subunits and is 20–
25 ˚ A from the binding site of the thiamine pyrophosphate
cofactor. The primary sequence of the active-site loop is
conserved among plant and mammalian PDC E1 proteins,
and, while sequence conservation with BCKDC is less,Enzyme Research 3
both loops have a similar structure [16, 17] suggesting that
the individual residues (conserved or variable) perform the
same biochemical function.
Site-directed mutagenesis of the active-site loop from
mammalian PDC E1α highlighted the roles of Arg267 in
binding the carboxyl group of pyruvate and Asp276, Tyr281,
and Arg282 in both decarboxylation of pyruvate and the
subsequent reductive acetylation of the lipoyl domains of
E2 [18]. In addition, Ala scanning mutagenesis of the
active-site loop of RnBCKDC E1α provided evidence that
Arg288, His292, and Asp296 are also involved in catalysis
[19, 20]. Moreover, the clinically deleterious H263L and
R273C mutations of HsPDC E1α result in greatly reduced
PDC activity [21, 22]. These residues correspond to Arg287,
His291, Asp295, Tyr300, and Arg301 of the Arabidopsis
thaliana PDC E1α (AtPDC E1α)s e q u e n c e( Figure 1).
To better understand the catalytic mechanisms and
regulatory properties of the plant mitochondrial PDC,
it was necessary to develop a method to produce the
recombinant enzyme that is both soluble and correctly
assembled into the α2β2 heterotetramer. Previous attempts
touseBacillus subtilis [23]andPichia pastoris [24]expression
systems were plagued by problems with protein solubility
and stability and codon usage bias. Herein, we describe a
two-plasmid approach for expression of catalytically active
heterotetrameric AtPDC E1 in Escherichia coli.U s i n ga
minimum in vitro assay system of recombinant AtPDC
E1 and AtPDK, we have begun detailed analyses of the
reversible phosphorylation of E1. We veriﬁed that the
Ser residue corresponding to mammalian site 1 is a site
of regulatory phosphorylation. Additionally, we targeted
Asp295 and Gly297, residues conserved in the active-site
loop but not previously tested for their contribution(s) to
the catalytic activity of E1, and role(s) in phosphorylation-
site recognition by PDK. Our results suggest that Asp295,
but not Gly297, is involved in both E1 catalysis and
phosphorylation.
2.ExperimentalProcedures
2.1. Plasmid Construction. A two-plasmid system was used
for expression of AtPDC E1. Primers DDR321 and 322
(see Table S1 in Supplementary Material available online at
doi:10.4061/2011/939068) were used to amplify the AtPDC
E1α reading frame [25]. The DDR321 primer includes a
NdeI site, a H6-aﬃnity tag, and starts with S18 of E1α,t h e
ﬁrst residue after the N-terminal mitochondrial targeting
sequence. The PCR product was cut with NdeI and XhoI,
then ligated with similarly digested pT7-7 [26], yielding
pDDR-E1α.
Similarly, primersDDR323and 324(Table S1)were used
to amplify the AtPDC E1β reading frame [27]. The DDR323
primer includes a NcoI site, the FLAG epitope (DYKD-
DDDK) [28], and starts with A30 of E1β, the ﬁrst residue
after the N-terminal mitochondrial targeting sequence. The
PCR product was digested with NcoI and HinDIII, then
ligated with similarly digested pET28 (Novagen, Madison,
WI, USA), yielding pDDR-E1β.
2.2. Protein Expression and Puriﬁcation. The E. coli BL21
(DE3) host cells (Novagen, Madison, WI, USA) were
sequentially transformed to express the GroE chaperonins
[29], AtPDC E1β-pET28, and ﬁnally AtPDC E1α-pT7-7.
Protein expression was induced by adding IPTG to a ﬁnal
concentration of 0.1mM. Individual transformants were
screened for high-level expression of soluble AtPDC E1.
Cell growth, lysis, and aﬃnity puriﬁcation of recombinant
AtPDC E1 and AtPDK are described elsewhere [30].
2.3. Size-Exclusion Chromatography. Assembly of heterote-
trameric AtPDC E1 was determined by size-exclusion chro-
matography. A Superose 12 column (Amersham Pharmacia
Biotech, Piscataway, NJ, USA) was equilibrated with 50mM
TES-NaOH, pH 7.4, containing 50mM NaCl, 0.1 mM TPP,
and 0.2mM MgCl2. Column fractions were analyzed by
SDS-PAGE, and the AtPDC E1 subunits were detected by
immunoblotting [31]. The E1α monoclonal antibodies have
been previously described [32]. Anti-FLAG antibodies were
from the Sigma Chemical Co. (St. Louis, MO, USA).
2.4. Site-Directed Mutagenesis. Site-directed mutagenesis of
AtPDC E1α was accomplished using the QuikChange kit
from Stratagene (La Jolla, CA, USA). The S292D/S298A
double mutant was constructed by preparing the S298A
mutant ﬁrst, then using it as the template for a second
round of mutagenesis. The mutagenic primer pairs were
DDR162 and DDR163 (S292A), DDR431 and DDR432
(S298A), DDR425 and DDR426 (S292D), DDR444 and
DDR445(G297S),DDR446andDDR447(G297D),DDR448
andDDR449(D295N),DDR450and DDR451(D295A),and
DDR452 and DDR453 (D295L) (Table S1). All mutations
were veriﬁed by DNA sequencing.
2.5. Far-UV Circular Dichroism Spectroscopy. The various
expressed E1 proteins were examined by far-UV CD spec-
troscopy using an AVIV Model 202 spectrometer (Piscat-
away, NJ, USA) to determine if the site mutations intro-
duced any signiﬁcant perturbation in AtPDC E1 structure.
Samples were analyzed at room temperature using a 0.1cm
path-length cuvette, and spectra were recorded from 190
to 300nm at 1nm intervals with a bandwidth of 1nm.
For each analysis, 200μL of puriﬁed protein in 20mM
KH2PO4/K2HPO4 (pH 7.4) at a concentration of 100–
200μg/mL was used.
2.6. Phosphorylation of AtPDCE1. Phosphorylation was
determined by measuring the incorporation of [32P] from
[γ-32P]ATP (6000Ci/mmole, Perkin-Elmer, Boston, MA,
USA)intoAtPDCE1.RecombinantE1(1μg)wasmixedwith
recombinant AtPDK (0.25μg )a n dk e p tf o r3 0m i no ni c e .
Reactions were conducted at 30◦Ci n2 0 m MT E S - N a O H ,
pH 7.4, containing 5mM MgCl2,5 0m MK C l ,a n d0 . 2m M
total ATP. Reactions were terminated after 90min by adding
1/5 volume of 5x SDS-PAGE sample buﬀer (15% (w/v) SDS,
15% (v/v) 2-mercaptoethanol, 50% (v/v) glycerol). Proteins
were resolved by SDS-PAGE, electroblotted to nitrocellulose,
and examined by autoradiography. The incorporation of4 Enzyme Research
radiolabel into AtPDC E1 was quantiﬁed by liquid-
scintillationspectrometry ofthebands excised from Ponceau
S stained membranes.
2.7. Peptide Mass Mapping of Phosphorylated E1α by Matrix-
Assisted Laser Desorption/Ionization Time-of-Flight Mass
Spectrometry. The AtPDC E1α S298A mutant was phospho-
rylated by AtPDK using nonradioactive ATP. After SDS-
PAGE, the AtPDC E1α band was excised and subjected
to in-gel tryptic digestion. Desalted tryptic peptides in
acetonitrile/water/88% formic acid (700/290/10, V/V/V)
were applied to a 96x2 hydrophobic stainless steel target
and topped with an equal volume of a 10-mg/mL solution
of alpha-cyano-4-hydroxycinnamic acid (Fluka, St. Louis,
MO, USA) in acetonitrile/water/10% triﬂuoroacetic acid
(600/370/30,V/V/V).Thesampleandmatrixwereallowedto
cocrystallize under ambient conditions. Matrix-assisted laser
desorption/ionization time-of-ﬂight (MALDI TOF) mass
spectrometry was performed with an Applied Biosystems
Voyager DEPro instrument equipped with a 20-Hz 337-
nm nitrogen laser (Applied Biosystems, Inc., Foster City,
CA, USA). Negative ion spectra were acquired in the linear
delayed extraction mode under optimized conditions using
close-external calibration based on a commercial mixture of
peptides (Applied Biosystems).
2.8. Tandem MS Analysis of Tryptic Peptides. The desalted
tryptic peptides from the phosphorylated AtPDCE1α S298A
mutant protein were analyzed by nanospray quadrupole
time-of-ﬂight mass spectrometry (Q-TOF MS) using an
Applied Biosystems/MDS Sciex (Foster City, CA, USA)
QStar/Pulsar instrument ﬁtted with a nanospray source
(Proxeon Biosystems, Odense, Denmark). A stable spray
was achieved at 750V in the presence of nitrogen cur-
tain gas for sample dissolved in acetonitrile/water/88%
formic acid (500/490/10, V/V/V). Positive ion spectra were
acquired in the proﬁle MCA mode at a pulser frequency of
6.99kHz. Collision-induced dissociation spectra (MS/MS)
were acquired for peptides selected by the ﬁrst quadrupole
at low resolution (3–5amu window) and fragmented in the
collision quadrupole at appropriate nitrogen collision gas
pressuresandcollisionenergysettings.Fragmentedionswere
assigned nomenclature according to [33].
2.9. Measurement of Catalytic Activity. The catalytic activity
of WT AtPDC E1 and site-directed mutants was deter-
mined by assaying the decarboxylation of [1-14C] pyruvate
(20mCi/mmol, Perkin-Elmer, Boston, MA, USA) in the
presence of 1.0mM K3Fe(CN)6 as the electron acceptor
[34]. Reactions were preincubated for 2min at 30◦Cb e f o r e
adding 1mM [1-14C] pyruvate and 1μgA t P D CE 1 .O n e
unit of enzyme activity is 1μmol of CO2 released per min
at 30◦C. All of the data presented comprise a minimum of
two biological replicates plus three technical replicates.
Kinetic constants were determined by measuring decar-
boxylation of pyruvate in the presence of 1.8μMK 3Fe(CN)6.
The lower concentration of K3Fe(CN)6 reduced the oth-
erwise high and variable background values to near zero.
A ﬁxed variable concentration of pyruvate ranging from
50 to 900μMw a su s e dw i t h1 μgA t P D CE 1 .D a t aw e r e
ﬁtted to the appropriate equations using the program
Origin7(OriginLabCorporation,Northampton,MA,USA).
The Km and kcat values were determined from initial-rate
measurementsandﬁttotheequationv = (kcat×S)/(Km +S ) ,
where S = substrate concentration.
2.10. Bacterial Two-Hybrid Analysis. Interactions between
AtPDK and AtPDC E1α were analyzed using the bacterial
two-hybrid (B2H) system (BacterioMatch I, Stratagene, La
Jolla, CA, USA). Primers DDR471 and DDR472 were used
to amplify WT AtPDK [30], while primers DDR473 and
DDR474 were used to amplify both WT and mutant forms
of E1α. The AtPDK sequence was cloned into pBT, and
the AtE1α constructs were cloned into pTRG. Pairs of
constructs were used to cotransform the E. coli Bacterio-
Match I reporter strain. Selection was on Luria-Bertani
agar containing 250μg/mL carbenicillin, 12.5μg/mL tetracy-
cline, 34μg/mL chloramphenicol, and 50μg/mL kanamycin.
Cells selected by antibiotic screening were additionally
screened on LB plates containing 80μg/mL X-gal plus
0.2mM β-galactosidase inhibitor (to inhibit endogenous
β-galactosidase). Interactions between PDK and the E1α
mutants were quantiﬁed by measuring β-galactosidase activ-
ity [35, 36]. The microplate spectrophotometric assay uses
o-nitrophenyl-β-D-galactoside as the substrate.
3.Results
3.1. In Silico Analysis of the E1α Active-Site Loop. The active-
site loop is a structural feature critical for both catalysis
by E1 and phosphorylation of E1 by PDK. Overall, there
is 50% sequence identity among the amino acid residues
that comprise the active-site loop of diverse members of
the α-ketoacid dehydrogenase family (Figure 1(a)). Two
of the conserved residues were targeted in this study,
Asp295 and Gly297. Located three residues C-terminal of
phosphorylation site 1 (Ser292), Asp295 is the only acidic
residueinproximitytothisphosphorylationsite.Itisentirely
conserved among α-ketoacid dehydrogenase sequences.
The primary sequence of AtPDC E1α was threaded
through the crystal structure of HsE1α [17]. The resulting
model indicates that Asp295 protrudes into the loop and
can interact with His291 and Tyr300 (Figure 1(b)). The
results from in silico mutagenesis of Asp295 indicate that
these interactions would be disrupted if the hydrophilic side
chain was replaced with an uncharged polar residue, that
is, D295N. In the D295A and D295L mutants, interactions
with His291 and Tyr300 would be completely abolished.
The active-site loop is a highly charged region. If Asp295
plays a structural role in maintaining the structure of the
loop, the mutations would disrupt substrate binding and/or
interaction with AtPDK.
Of the ﬁve residues proximal to Ser292, Gly297 is
conserved in eukaryotic PDC sequences, but not in those of
the BCKDC. Since Gly297 is not in the immediate vicinity
of Ser292, mutation would not be expected to directly aﬀectEnzyme Research 5
phosphorylation of E1 but might still be involved with either
presentation of the phosphorylation site to the kinase-active
site or catalysis. The corresponding position in BCKDC
contains a Ser residue suggesting that a small residue at this
position may be suﬃcient for the structural conformation of
the active-site loop. In silico, the G297D and G297S mutants
do not aﬀect the N-terminal interactions of Asp295 but
induce an additional interaction with Arg301 (Figure 1(c)).
3.2. Expression of Recombinant AtPDCE1. At w o - p l a s m i d
approach was employed for expressing high yields of
correctly assembled and fully active α2β2 heterotetrameric
AtPDC E1 in E. coli. Expression of only the AtPDC E1α or
E1β subunits individually invariably yielded only insoluble
subunits (Figure 2(a)), while coexpression of the α-a n dβ-
subunits resulted in a substantial amount of soluble protein
(Figure 2(b)). Immobilized metal aﬃnity chromatography
was used to purify recombinant AtPDC E1; analysis of
the puriﬁcation steps by SDS-PAGE is shown in Figures
2(b) and 2(c). The co-occurrence of α-a n dβ-subunits was
veriﬁedby immunoblotting(Figure 2(d)).Based uponvisual
examination of Coomassie Blue-stained SDS gels, it was
estimated that ﬁnal preparations of AtPDC E1 were ∼95%
pure.
To conﬁrm the assembly of heterotetrameric AtPDC
E1, the puriﬁed protein was subject to size-exclusion chro-
matography. Most recombinant protein eluted from the
Sepharose 12 column at a position corresponding to an
Mr value of 160,000, which is what would be expected
for an α2β2 heterotetramer. The far-UV CD spectra of the
E1 proteins indicated no signiﬁcant changes in secondary
structurebetweenWT AtPDCE1and any ofthe site-directed
mutants (data not presented).
3.3.CatalyticActivityofRecombinantAtPDCE1. Thespeciﬁc
activity values for the WT and mutant forms of AtPDC
E1 are shown in Table 1. The activity of the S292A mutant
was reduced by 25%, while there was no change in the
activity of the S298A mutant. In contrast, the activities
of the S292D and S292D/S298A mutants were reduced by
>90%. The activities of the G297D and G297S mutants were
reduced by 25 to 30%, while those of the D295A and D295N
mutants were reduced by 60%. The D295L mutant protein
was essentially inactive (1% residual activity).
The kinetic parameters of WT and the mutants, using
pyruvate as the variable substrate, are shown in Table 2.T h e
kcat values for the D295A and D295N mutants were reduced
∼70%. The Km pyruvate values for the D295A and D295N
mutants were increased 4- to 6-fold compared with WT
AtE1. The kcat value for the G297D mutant was reduced by
50% without any change in Km pyruvate. In these mutants,
the catalytic eﬃciency (kcat/Km) was reduced by 3.5 to 35-
fold, reduction that, although signiﬁcant, is modest for the
changes expected on mutation of residues directly involved
in substrate binding and/or catalysis.
3.4. Phosphorylation of AtPDC E1 In Vitro. Incubation of
WT AtPDC E1 with recombinant AtPDK using 200μM
Table 1: The speciﬁc activities of WT and mutant AtPDC E1
proteins were determined by assaying the decarboxylation of
[1-14C] pyruvate in the presence of 1.0 mM K3Fe(CN)6 as the
electron acceptor.
Enzyme Speciﬁc activity
(units/mg) %
WT AtPDCE1 0.32 ± 0.01 100
S292A 0.24 ± 0.06 74
S298A 0.31 ± 0.02 97
S292D 0.02 ± 0.03 6
S292D/S298A 0.03 ± 0.03 9
D295A 0.12 ± 0.01 37
D295N 0.12 ± 0.01 37
D295L 0.003 1
G297D 0.24 ± 0.03 75
G297S 0.22 ± 0.04 68
Table 2: Kinetic parameters of WT AtPDC E1 and site-directed
mutants. Activities were determined by assaying decarboxylation of
[1-14C] pyruvate in the presence of 1.8μMK 3Fe(CN)6.
Enzyme Km pyruvate
(μM) kcat (s−1) kcat/Km
(μM−1 s−1)
WTAtE1 45 ± 18 159 ±14 3.5
D295A 178 ± 108 52 ±12 0.3
D295N 257 ± 144 38 ±10 0.1
G297D 66 ± 24 70 ±71 . 0
[γ-32P] ATP resulted in the phosphorylation of a single
polypeptide species (Figure 3(a), lane 1). To analyze regu-
latory phosphorylation site 1 of AtPDC E1, three diﬀerent
mutants were constructed. The S292A mutant targets the
conserved phosphorylation site 1, while the S298A mutant
targets potential phosphorylation of the putative site 2. The
S292D/S298A double mutant was constructed to mimic
phosphorylation of AtPDC E1α Ser292 in the absence of a
residue that could be phosphorylated at site 2.
Incubation of the mutant proteins with recombinant
AtPDKplus200μM[γ-32P]A TPr esultedinphosphorylation
of a single polypeptide species for the S298A mutant
(Figure 3,l a n e3 ) .T h e r ew e r eo n l yt r a c ea m o u n t so f
phosphate incorporated into the S292A mutant (2% of WT)
and into the S292D/S298Adouble mutant (1% of WT).
3.5. Analysis of the Phosphorylated AtPDCE1α S298A Mutant
by Mass Spectrometry. To verify that Ser292 was the site
phosphorylated in vitro, the S298A mutant was phospho-
rylated with recombinant AtPDK plus unlabeled ATP, then
s u b j e c t e dt oi n - g e lt r y p t i cd i g e s t i o n .T h eM A L D I - T O FM S
analysis of the tryptic peptides revealed an ion at M-
H− 1656.9Da, which corresponds to the phosphopeptide
Tyr286-Arg301 (Figure 4(a)). This was the only peptide
detected by negative ion nanospray QqTOF precursor
ion analysis that yielded the diagnostic fragment ion for6 Enzyme Research
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Figure 2: Expression and puriﬁcation of A. thaliana pyruvate dehydrogenase. (a) Bacterial expression of AtPDC E1α and E1β.A nS D S
gel of total proteins from uninduced E. coli BL21 (DE3) cells containing pT7-7:AtE1α; insoluble (I.F.) and soluble (S.F.) fractions from
induced cells;total proteins fromuninduced cells containingpET28:AtE1β; insolubleandsolublefractions from induced cells.The positions
of AtPDC E1α and E1β are indicated by arrows. (b) An SDS gel of a typical 2-plasmid AtPDC E1 α plus β coexpression and puriﬁcation
proﬁle using the HiTrap chelating column charged with 0.1M NiSO4; insoluble fraction, soluble fraction, ﬂow through (F.T.). The position
ofAtPDCE1β inthesolublefractionisindicated by anarrow.(c)ACoomassie-stainedSDSgelofAtPDC E1afterimmobilizedmetalaﬃnity
chromatography. (d) Immunoblot analysis of AtPDC E1. The E1α subunit was detected with monoclonalanti-E1α antibodies, and the E1β
subunit was detected with monoclonalanti-FLAG antibodies. The positions of molecular mass markers are indicated on the left for (a) and
(b). All gels (except the Immunoblot) were stained with Coomassie Blue.
phosphopeptides, 78.96Da (the PO3
− ion). The sequence
of this peptide was conﬁrmed by positive ion nanospray
QqTOF tandem MS analysis of the triple-charge ion at
553.55Da in the peptide mixture (Figure 4(b)). The assign-
ment of phosphate to Ser292 is supported by the presence
of fragment ions b5+ (662.25Da), b6+ (793.23Da), and a
completey-ion series includingy10+ (1164.41Da).The most
plausible interpretation of these data is that the Tyr286-
Arg301 tryptic peptide is phosphorylated at Ser292. Tandem
MS analyses of the double-charge ion at 829.8Da and the
triple-charge ion for the Met-oxidised form of the peptide at
558.9Da provided additional evidence for phosphorylation
of Ser292 (data not shown).
3.6. Phosphorylation of the Asp295 and Gly297 Mutants.
Comparison of WT and mutant AtPDC E1 proteins incu-
bated with AtPDK for 90min showed substantial diﬀerences
in phosphorylation (Figures 5(a) and 5(b)). In compar-
ison with WT E1, phosphorylation of the D295A and
D295N mutants was reduced by 92 and 83%, respec-
tively, while phosphorylation of the D295L mutant was
abolished (∼3% residual phosphorylation) (Figure 5(a)).
In contrast, phosphorylation of the G297D and G297S
mutants was little aﬀected, being reduced 9 and 13%,
respectively.
The data in Figure 5(c) show a time-dependent increase
inphosphorylationoftheG297Dmutant,similartothatseenEnzyme Research 7
with the WT protein. In contrast, the low-level phosphory-
lation in the D295A and D295N mutant proteins did not
increase with an increase in time.
3.7.B2HAnalysis ofProteinInteractions. Interactionbetween
PDK and E1 in our reconstituted in vitro system comprises
a multistep sequence including recognition, binding, and
phosphotransfer. We used the B2H synthetic genetic system
to test the possibility that reduced phosphorylation of the
AtPDCE1αD295AandD295Nmutantswasduetoimpaired
binding of PDK. In these assays, protein interaction is
quantiﬁed using the β-galactosidase reporter. Interactions
between AtPDK and the mutant forms of AtPDC E1α were
slightly reduced relative to WT E1α (Figure 6). It does
not appear, however, that these small decreases in protein
interaction are adequate to explain the large decreases in
phosphorylation (Figure 5).
4.Discussion
Two approaches were used previously to express recombi-
nant plant mitochondrial PDC E1. Staphylococcal protein
A-based vectors were constructed to direct secretion of the
E1α and E1β subunits of P. sativum pyruvate dehydrogenase
from separate strains of B. subtilis [23]. A bipartite vector
was designed for simultaneous expression of E1α and E1β
subunits in the cytoplasm of P. pastoris, but very low yields
were the result of an unfavorable codon-usage bias [24].
While useful for analytical studies of E1 assembly, these
systems yielded too little protein for detailed biochemical
characterizations.
The envisioned analyses necessitated development of a
method for heterologous expression and rapid puriﬁcation
of active, correctly folded and assembled recombinant
AtPDC E1. The E. coli coexpression strategy routinely
yielded ∼8mg of puriﬁed E1 per 500mL, and more than
90% of this was assembled into heterotetramers. Catalytic
activity was seemingly not inﬂuenced by the N-terminal
His6-tag. When individually expressed at high levels neither
subunit was soluble, suggesting that correct folding and
assembly of large amounts of the heteromeric enzyme
require the simultaneous presence of both subunits.
Complexity in the folding and assembly pathway was not
unexpected based upon previous reports [23, 24, 37, 38]
and the reported participation of the GroE chaperonins
[39–41].
Recombinant tetrameric AtPDCE1 catalyzed decarboxy-
lation of pyruvate in the presence of high (1.0mM) and low
(1.8μM) concentrations of the artiﬁcial electron acceptor
K3Fe(CN)6 (Tables 1 and 2). The speciﬁc activity of the
recombinant enzyme was 0.32μmolmin−1 mg−1 protein in
assays containing 1mM K3Fe(CN)6.T h i si s∼2-fold higher
than the values reported for recombinant HsPDC E1 [42]
or native E. coli E1 [43] under similar assay conditions. The
Km pyruvate value for recombinant AtPDC E1 is similar to
that of native pea mitochondrial PDC [44] but cannot be
compared directlybecause ofdiﬀerencesin assay procedures.
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Figure 3: Phosphorylation of recombinant AtPDC E1 by recom-
binant AtPDK. (a) Autoradiograph of the in vitro phosphorylation
of wild-type (WT) AtE1α, and the S292A and S298A mutants, by
recombinant AtPDK. One μg of E1 was incubated with 0.25μg
PDK and 200μM[ γ-32P]ATP, at 30◦Cf o r9 0m i n .W h e nt h eﬁ l m
was developed after 3h, phosphorylation of the WT and the S298A
proteins wasvisible, whileno phosphorylationwasobserved for the
S292A and the double mutants. Furthermore, no phosphorylation
of the S292A or double mutants was observed when the same
ﬁlm was developed after 16h. (b) Phosphorylation of the mutant
proteins relative to WT. The 100% phosphorylation value of WT
was 1.0±0.04μmol 32Pm o lA t P D CE 1 −1. Data are the mean values
from at least three separate determinations ± SEM.
There are currently no literature kcat values for recombinant
E1 proteins.
The catalyticactivity ofthe AtPDCE1S292Amutantwas
reducedby26%(Table 1),which isessentially identicaltothe
eﬀect previously reported for HsPDC E1 [42]. The activity
of the AtPDC E1 S292D/S298A double mutant was reduced
by 90% (Table 1). Replacement of the HsPDC E1 site 1 Ser
residue with the P-Ser mimic Glu reduced decarboxylase
activity but abolished PDC activity. This result agrees with
the previous observations that phosphorylation has a more
pronounced eﬀe c to nr e d u c t i v ea c e ty l a t i o nt h a no ns u b s t r a t e
binding [43, 45].
Recombinant AtPDC E1 was eﬃciently phosphorylated
in vitro by AtPDK. One mole of phosphate was incorpo-
rated per mol of subunit dimer. (Figure 3). The slight 32P
incorporation on the S292A mutant and the unaﬀected
phosphorylation level of the S298A mutant catalyzed by8 Enzyme Research
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Figure 4: Analysis of the AtPDC E1α S298A mutant phosphorylation site by mass spectrometry. (a) MALDI-TOF MS analysis of tryptic
peptides from the AtPDC E1α S298A mutant. The 1656.9 m/z ion corresponds to the phosphopeptide Tyr286 to Arg301. (b) Fragmentation
of the m/z 1656.9 peptide by nanoelectrospray tandem MS. Fragment ion spectrum from the triple-charge molecular ion at m/z 553.55.The
ions b5+ (662.25), b6+ (793.23), and y10+ (1164.41) indicate P-Ser292. The asterisks mark the fragment ions from the S298A-methylated
peptide that was also present in the parent ion envelope at (M + 3H)3+ of 553.95Da. (c) Expanded spectrum of the y10+ ion.
AtPDK suggested that only Ser292 is phosphorylated in our
assay condition (Figure 3). Analysis of the S298A mutant by
QqTOF tandem MS veriﬁed phosphorylation of only Ser292
(Figure 4). Our ﬁnding that only site 1 is phosphorylated
with the reconstituted minimum A. thaliana system is in
agreement with results obtained using the recombinant
human proteins [46] and validate use of the plant system for
further mechanistic studies.
There is no reason to believe that the enzymatic
mechanism is somehow diﬀerent in the absence/presence
of E2. While the rate of E1 phosphorylation by PDK is
higher in the presence of E2 (and higher yet with PDC)
[47], this stimulation is due to a direct kinetic eﬀect; that
is, ADP disassociates faster from PDK when it is bound
to E2 [48]. Our results are consistent with a previous
study, using two-dimensional separation ofphosphoproteinsEnzyme Research 9
45
Mr ×10−3
W
T
D
2
9
2
A
D
2
9
5
N
D
2
9
5
L
W
T
G
2
9
7
D
G
2
9
7
S
Mr ×10−3
45
(i) (ii)
(a)
0
20
40
60
80
100
W
T
D
2
9
5
A
D
2
9
5
N
D
2
9
5
L
G
2
9
7
D
G
2
9
7
S
P
h
o
s
p
h
o
r
y
l
a
t
i
o
n
(
%
W
T
)
(b)
0
0.1
0.2
0.3
0.4
02 04 0 6 0
[
3
2
P
]
p
h
o
s
p
h
a
t
e
i
n
c
o
r
p
o
r
a
t
e
d
(
m
o
l
/
m
o
l
E
1
)
Time (min)
(c)
Figure 5: Phosphorylation of AtPDC E1α active-site loop mutants by AtPDK. (a) (i) Autoradiograph comparing phosphorylation of WT
AtPDC E1 and the Asp295 mutant. (a) (ii) Autoradiograph comparing phosphorylation of WT AtPDC E1 and the Gly297 mutant. One μg
each of the WT and mutant proteins was incubated with 0.25μg AtPDK and 200μM[ γ-32P]ATP at 30◦C for 90min. In each case the entire
reaction mixture was loaded onto the gels. After electrophoresis, all gels were exposed to ﬁlm for 3h. (b) Relative (to WT) phosphorylation
of the Asp295 and Gly297 mutants is indicated. Data are mean values from at least three separate determinations ± SEM. The value for
100% ofWT phosphorylationwas 0.7±0.02μmol 32P μmolAtPDC E1−1. (c) Time-course ofphosphorylation.The WT AtPDC E1 (
￿), and
the G297D (
￿), D295A ( ), and D295N (
￿) mutant proteins, were phosphorylated as described in (a). Reactions volumes were 100μL.
Samples of 20μL were removed at each time point, mixed with SDS-sample buﬀer, heated, and then resolved by SDS-PAGE.
from potato mitochondria followed by MS analysis, which
identiﬁed Ser292 as the only residue phosphorylated [49].
While phosphorylation of only site 1 was expected with
the minimum in vitro system, multi-site phosphorylation
remains a possibility upon addition of E2 or more likely as
PDC.
Phosphorylation of Ser292 was aﬀected considerably by
changes to Asp295, being reduced in the order D295N <
D295A < D295L (Figure 5(a)). Interaction between E1α and
PDK is a multistep process that involves recognition of
the phosphorylation-site region, docking of the PDK with
thisregion,andsubsequenttransferofthephosphorylgroup.
It is unlikely that the major reduction in phosphorylation
of these mutants was due to inhibition of PDK binding to
E1, because there was no signiﬁcant reduction of interac-
tion between AtPDK and the D295N or D295A mutants
(Figure 6). It is logical that the reduction in phosphorylation
of the active-site loop mutants is due to disruption of the
transferoftheγ-phosphatefromATPtoE1αSer292,possibly
the result in ordering or positioning of the active-site loop.10 Enzyme Research
Some protein Ser/Thr kinases have an aﬃnity for
amino acids with acidic, basic, or hydrophobic functional
groups located at deﬁned positions N- or C-terminal to
the phosphorylation site [50]. Our results are similar to an
earlier study employing synthetic peptides as substrates for
PDK. In those studies, peptides with the D295N substitution
were poorer substrates for bovine PDK [8]. The Asp295
residue is one of a group of charged residues that form
an H-bonding network that stabilizes the active-site loop
[51], making it accessible to the lipoyl domain of E2.
P e r t u r b a t i o n si nt h i sn e t w o r ka ﬀect substrate channeling,
and phosphorylation is believed to promote this disorder
[45, 51]. Based on the results from in silico mutagenesis,
we hypothesize that interactions with His291 and Tyr300
would be disrupted if Asp295 were substituted (Figure 1(b)).
Even substitution with Glu would be predicted to abolish
the H-bond with His291, although we did not test this
experimentally. The reduced phosphorylation seen with all
changes to Asp295 is consistent with the proposal that
altering the acidic residue C-terminal to Ser292 destabilizes
the structure of the active-site loop. Alternatively, it is
possible that conservation of Asp295 is part of a mechanism
that maintains the active-site loop disordered and provides
access to Ser292.
Changes to Asp295 have been reported to have pleio-
tropic eﬀects on phosphorylation of E1. Phosphorylation of
RnBCKDC E1 was not aﬀected by mutagenesis of Asp295
[19], but was inhibited by mutagenesis of Arg288, which
corresponds to Arg285 of AtPDC E1α. In contrast, the
same mutations of HsBCKDC E1 did not inhibit phos-
phorylation [51]. The D296E mutant in HsPDC E1α was
still phosphorylated, although in these analyses the eﬀect of
phosphorylationwasdeterminedindirectlybymeasuring the
decrease in activity of an already catalytically compromised
mutant protein [52].
The catalytic response to the D295A change has been
studied in other systems but using a similar assay method,
which simpliﬁes comparisons. In the case of AtPDC E1,
the catalytic activities of the D295A and D295N mutants
were reduced considerably(Table 1). The Km pyruvate values
of these mutant proteins were increased 5-fold, while the
kcat decreased by >70%. The response of the HsBCKDC E1
to the D295A mutation was essentially the same as with
AtPDC E1 in terms of catalytic activity and kcat values;
however, in that instance, the Km pyruvate was unaﬀected
[51]. In a case of extreme contrasts, this D > Am u t a t i o n
of RnBCKDC E1 yielded a catalytically dead protein [19],
while the activity of the B. stearothermophilus PDC E1α
actually increased 3-fold (and the Km pyruvate value by
10-fold) [18]. The modest but consistent reduction in kcat
and kcat/Km values seen with the AtPDC E1 mutants are
in agreement with the proposal that Asp295 stabilizes the
active-site loop conformation. The diﬀerences seen with
ostensibly closely related enzymes suggest small or subtle
diﬀerences in loop structure or stability. In the case of the
more structurally distant E. coli PDC E1, the H-bonding
loop-stabilizing pattern also involves nonconserved residues
[53].
0
20
40
60
80
100
W
T
D
2
9
5
A
D
2
9
5
N
R
e
l
a
t
i
v
e
a
c
t
i
v
i
t
y
(
%
)
Figure 6: Quantitative analysis of interactions between AtPDC
E1 and AtPDK. Quantitative B2H analysis was used to study
interaction between WT AtPDC E1α, the D295A, and D295N
mutants and AtPDK. The AtPDK sequence was cloned into the
Stratagene B2H vector pBT, while the E1α sequences were cloned
into pTRG. After selection, protein interactions were quantiﬁed
using the β-galactosidase reporter. The value for 100% of WT
activity was 3μmolmin−1 1.0 A600−1.D a t aa r et h em e a n± SEM
from two separate experiments, each assayconducted in triplicate.
Binding of the TPP cofactor confers an ordering to
the E1α active-site loop. When the site 1 Ser residue
is phosphorylated, the presence of the phosphoryl group
prevents this ordering [53]. The mechanism involved has
been referred to as a “steric clash” between the P-Ser at site
1 and a nearby Ser residue which then nulliﬁes a hydrogen-
bonding network [45]. Some of the eﬀects that we have seen
with the AtPDC E1α Asp295 mutants could be explained
by this same mechanism. The disordered phosphorylation
loops impede the binding of lipoyl domains of the PDC E2-
core to E1 [45]. The importance of structural order/disorder
on protein phosphorylation is the subject of much current
attention [54, 55].
The conserved Gly297 residue does not have an obvious
role in the phosphorylation of the site 1 Ser residue.
Phosphorylation was not aﬀected in either the G297S
mutant, where residue size is similar, or the G297D mutant
which represents a drastic change (Figure 5(b)). These
results seem to indicate that the residue present in this
position is not directly involved with either formation or
stabilization of the active-site loop structure. The reduc-
tion in kcat, without any change in Km pyruvate, suggests
that replacing Gly297 with a polar residue, such as Asp,
might be interfering with interactions between Tyr-300Enzyme Research 11
and the carboxyl group of pyruvate, either directly or via
steric hindrance.
Since all of the mutant subunits assembled into heterote-
tramers, neither Asp295 nor Gly297 is critical for subunit
association. Moreover, the far-UV CD spectra of the mutant
proteins were not distinguishable from the spectra obtained
for the WT protein (data not presented), indicating that no
gross structural perturbations occurred as a result of the
mutations.
The deﬁned in vitro system that we have developed is
suitable for additional detailed analyses of the mechanism
of regulatory phosphorylation of the plant mitochondrial
PDC. Future studies will include the recombinant plant E2
proteins and domains and will address the diﬀerences in
behavior between the mono- and dilipoyl forms of this core
component of the PDC [56].
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